David has worked in the Research & Enterprise Office at University of Otago since January 2005 as an Enterprise Manager leading the Biomedical sector, spanning the Health Sciences and Sciences Divisions of the University.

David’s role involves client engagement, project management and promotion of the University of Otago’s research with the main objective to increase the University’s external relationships and research funding from within New Zealand and Internationally with the main focus being in Asia e.g. Japan, Singapore, Taiwan, Malaysia, Korea and China.

Diagnostics are vital tools identify diseases, enable personalised treatments, avoid drug resistance and enhance clinicians information for decision making. Point of care devices (POC) are required to provide a quick turnaround result. POC devices must be tailored to clinical need in the disease area and development needs to be informed by clinicians as to what will be useful, add value, save time and money.

The University of Otago has a wide range of expertise and capability in multiple disease areas for both the identification of diagnostic biomarkers as well as the development and validation of diagnostic tools.